Serum phospholipid fatty acids, genetic variation in myeloperoxidase, and prostate cancer risk in heavy smokers: A gene-nutrient interaction in the carotene and retinol efficacy trial

American Journal of Epidemiology

Volumn 177, Issue 10, 2013, Pages 1106-1117

  Cheng, Ting Yuan David ^a   King, Irena B ^a   Barnett, Matt J ^a   Ambrosone, Christine B ^a   Thornquist, Mark D ^a   Goodman, Gary E ^a   Neuhouser, Marian L ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

Author keywords

gene environment interaction; myeloperoxidase; polyunsaturated fatty acids; prostate cancer; trans fatty acids

Indexed keywords

ARACHIDONIC ACID; CAROTENE; DIHOMO GAMMA LINOLENIC ACID; DOCOSAHEXAENOIC ACID; DOCOSAPENTAENOIC ACID; FATTY ACID; ICOSAPENTAENOIC ACID; MYELOPEROXIDASE; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; RETINOL; TRANS FATTY ACID;

BIOASSAY; CANCER; CONFIDENCE INTERVAL; DISEASE INCIDENCE; FATTY ACID; GENE; GENETIC VARIATION; GENOTYPE; OXIDATION; PHOSPHOLIPID; SERUM; SMOKING;

ADULT; ARTICLE; CANCER INCIDENCE; CANCER RISK; CANCER STAGING; CONTROLLED STUDY; DRUG EFFICACY; FATTY ACID BLOOD LEVEL; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PROSTATE CANCER; SMOKING;

GENE-ENVIRONMENT INTERACTION; MYELOPEROXIDASE; POLYUNSATURATED FATTY ACIDS; PROSTATE CANCER; TRANS-FATTY ACIDS;

AGED; CASE-CONTROL STUDIES; FATTY ACIDS, UNSATURATED; HUMANS; MALE; MIDDLE AGED; OXIDATIVE STRESS; PEROXIDASE; POLYMORPHISM, GENETIC; PROSTATIC NEOPLASMS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS; SMOKING;

BALTIMORE; CALIFORNIA; CONNECTICUT; IRVINE; MARYLAND; NEW HAVEN; OREGON; SAN FRANCISCO [CALIFORNIA]; SEATTLE; UNITED STATES; WASHINGTON [UNITED STATES];

EID: 84877758086     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kws356     Document Type: Article

References (34)

1. Kolonel LN. Fat, meat, and prostate cancer. Epidemiol Rev. 2001;23(1):72-81
2. Astorg P. Dietary n-6 and n-3 polyunsaturated fatty acids and prostate cancer risk: A review of epidemiological and experimental evidence. Cancer Causes Control. 2004;15(4): 367-386
3. Rose DP. Effects of dietary fatty acids on breast and prostate cancers: Evidence from in vitro experiments and animal studies. Am J Clin Nutr. 1997;66(6 suppl): 1513S-1522S.
4. De Caterina R. n-3 Fatty acids in cardiovascular disease. N Engl J Med. 2011;364(25):2439-2450
5. Catala A. A synopsis of the process of lipid peroxidation since the discovery of the essential fatty acids. Biochem Biophys Res Commun. 2010;399(3):318-323
6. Trzeciak AR, Nyaga SG, Jaruga P, et al. Cellular repair of oxidatively induced DNA base lesions is defective in prostate cancer cell lines, PC-3 and DU-145. Carcinogenesis. 2004; 25(8):1359-1370
7. Khandrika L, Kumar B, Koul S, et al. Oxidative stress in prostate cancer. Cancer Lett. 2009;282(2):125-136
8. Forsberg L, de Faire U, Morgenstern R. Oxidative stress, human genetic variation, and disease. Arch Biochem Biophys. 2001;389(1):84-93
9. Spickett CM, Jerlich A, Panasenko OM, et al. The reactions of hypochlorous acid, the reactive oxygen species produced by myeloperoxidase, with lipids. Acta Biochim Pol. 2000; 47(4):889-899
10. Piedrafita FJ, Molander RB, Vansant G, et al. An Alu element in the myeloperoxidase promoter contains a composite SP1-thyroid hormone-retinoic acid response element. J Biol Chem. 1996;271(24):14412-14420
11. Choi JY, Neuhouser ML, Barnett MJ, et al. Iron intake, oxidative stress-related genes (MnSOD and MPO) and prostate cancer risk in CARET cohort. Carcinogenesis. 2008;29(5): 964-970
12. Cheng TY, Barnett MJ, Kristal AR, et al. Genetic variation in myeloperoxidase modifies the association of serum alphatocopherol with aggressive prostate cancer among current smokers. J Nutr. 2011;141(9):1731-1737
13. King IB, Kristal AR, Schaffer S, et al. Serum trans-fatty acids are associated with risk of prostate cancer in β-Carotene and Retinol Efficacy Trial. Cancer Epidemiol Biomarkers Prev. 2005;14(4):988-992
14. Smith BK, Robinson LE, Nam R, et al. Trans-fatty acids and cancer: A mini-review. Br J Nutr. 2009;102(9):1254-1266
15. Omenn GS, Goodman GE, Thornquist MD, et al. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med. 1996;334(18): 1150-1155
16. Choi JY, Neuhouser ML, Barnett M, et al. Polymorphisms in oxidative stress-related genes are not associated with prostate cancer risk in heavy smokers. Cancer Epidemiol Biomarkers Prev. 2007;16(6):1115-1120
17. Folch J, Lees M, Sloane Stanley GH. A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem. 1957;226(1):497-509
18. Lepage G, Roy CC. Direct transesterification of all classes of lipids in a one-step reaction. J Lipid Res. 1986;27(1): 114-120
19. Ambrosone CB, Ahn J, Singh KK, et al. Polymorphisms in genes related to oxidative stress (MPO, MnSOD, CAT) and survival after treatment for breast cancer. Cancer Res. 2005; 65(3):1105-1111
20. Mikhak B, Hunter DJ, Spiegelman D, et al. Manganese superoxide dismutase (MnSOD) gene polymorphism, interactions with carotenoid levels and prostate cancer risk. Carcinogenesis. 2008;29(12):2335-2340
21. Shui IM, Mucci LA, Kraft P, et al. Vitamin D-related genetic variation, plasma vitamin D, and risk of lethal prostate cancer: A prospective nested case-control study. J Natl Cancer Inst. 2012;104(9):690-699
22. Ahn J, Gammon MD, Santella RM, et al. Myeloperoxidase genotype, fruit and vegetable consumption, and breast cancer risk. Cancer Res. 2004;64(20):7634- 7639
23. Chavarro JE, Stampfer MJ, Li H, et al. A prospective study of polyunsaturated fatty acid levels in blood and prostate cancer risk. Cancer Epidemiol Biomarkers Prev. 2007;16(7): 1364-1370
24. Sfanos KS,Wilson BA, De Marzo AM, et al. Acute inflammatory proteins constitute the organic matrix of prostatic corpora amylacea and calculi in men with prostate cancer. Proc Natl Acad Sci U S A. 2009;106(9):3443-3448
25. Bartsch H, Nair J, Owen RW. Dietary polyunsaturated fatty acids and cancers of the breast and colorectum: Emerging evidence for their role as risk modifiers. Carcinogenesis. 1999;20(12):2209-2218
26. Fan YY, Ran Q, Toyokuni S, et al. Dietary fish oil promotes colonic apoptosis and mitochondrial proton leak in oxidatively stressed mice. Cancer Prev Res (Phila). 2011; 4(8):1267-1274
27. Fan YY, Zhan Y, Aukema HM, et al. Proapoptotic effects of dietary (n-3) fatty acids are enhanced in colonocytes of manganese-dependent superoxide dismutase knockout mice. J Nutr. 2009;139(7):1328-1332
28. Morrow JD, Frei B, Longmire AW, et al. Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. Smoking as a cause of oxidative damage. N Engl J Med. 1995;332(18):1198-1203
29. Wortman P, Miyazaki Y, Kalupahana NS, et al. n3 and n6 polyunsaturated fatty acids differentially modulate prostaglandin E secretion but not markers of lipogenesis in adipocytes. Nutr Metab. 2009;6(5). (doi: 10.1186/1743-7075-6-5).
30. Pettazzoni P, Pizzimenti S, Toaldo C, et al. Induction of cell cycle arrest and DNA damage by the HDAC inhibitor panobinostat (LBH589) and the lipid peroxidation end product 4-hydroxynonenal in prostate cancer cells. Free Radic Biol Med. 2011;50(2):313-322
31. Mannisto S, Pietinen P, Virtanen MJ, et al. Fatty acids and risk of prostate cancer in a nested case-control study in male smokers. Cancer Epidemiol Biomarkers Prev. 2003;12(12): 1422-1428
32. Brasky TM, Till C, White E, et al. Serum phospholipid fatty acids and prostate cancer risk: Results from the Prostate Cancer Prevention Trial. Am J Epidemiol. 2011;173(12): 1429-1439
33. Fan YY, Chapkin RS. Importance of dietary ?-linolenic acid in human health and nutrition. J Nutr. 1998;128(9):1411-1414
34. Wacholder S, Chanock S, Garcia-Closas M, et al. Assessing the probability that a positive report is false: An approach for molecular epidemiology studies. J Natl Cancer Inst. 2004; 96(6):434-442